CLDN4 and breast carcinoma: Taken collectively with the finding showing that LXRs greatly contribute to maintaining cholesterol homeostasis and fatty acid metabolism in normal and cancer cells [43, 44], these results suggested that CLDN4 promotes breast cancer metabolism through LXRs.